ANDEL INST VAN has a total of 16 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are PHIGENIX INC, PASTORAL AGRIC RES INST NZ LTD and VITAMFERO.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Agriculture | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Animal care | |
#5 | Measuring microorganism processes | |
#6 | Climate change adaptation technologies | |
#7 | Microorganisms | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Duesbery Nicholas S | 4 |
#2 | Webb Craig P | 4 |
#3 | Vande Woude George | 3 |
#4 | Alberts Arthur S | 3 |
#5 | Koo Han-Mo | 3 |
#6 | Vande Woude George F | 3 |
#7 | Takashi Masayuki | 2 |
#8 | Teh Bin Tean | 2 |
#9 | Zhang Nian | 2 |
#10 | Haab Brian | 2 |
Publication | Filing date | Title |
---|---|---|
WO03054151A2 | Generation of transgenic mice by transgene-mediated rescue of spermatogenesis | |
WO02079411A2 | Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification | |
AU2002255852B2 | Anthrax lethal factor inhibits tumor growth and angiogenesis | |
CA2419567A1 | Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma | |
AU7010101A | Conserved diaphanous-related formin autoregulatory domain (dad) |